​

Sabra Health Care REIT (SBRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SBRA Stock Forecast

Sabra Health Care REIT (SBRA) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $17.29, with a high of $20.00 and a low of $13.00. This represents a -4.69% decline from the last price of $18.14.

$13 $14 $15 $16 $17 $18 $19 $20 High: $20 Avg: $17.29 Low: $13 Last Closed Price: $18.14

SBRA Stock Rating

Sabra Health Care REIT stock's rating consensus is Hold, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (42.86%), 12 Hold (57.14%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 21 0 12 9 Strong Sell Sell Hold Buy Strong Buy

SBRA Price Target Upside V Benchmarks

TypeNameUpside
StockSabra Health Care REIT-4.69%
SectorReal Estate Stocks 20.09%
IndustryHealthcare REIT Stocks17.97%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$17.25
Last Closing Price$18.14$18.14$18.14
Upside/Downside---4.91%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25167--14
Mar, 25167--14
Feb, 25167--14
Jan, 25177--15
Dec, 24-87--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 12, 2024Nicholas JosephCitigroup$20.00$18.358.99%10.25%
Sep 03, 2024Michael LewisTruist Financial$18.00$17.005.88%-0.77%
Jun 21, 2024David RodgersRobert W. Baird$16.00$14.559.97%-11.80%
May 15, 2024Nicholas YulicoScotiabank$15.00$14.672.25%-17.31%
May 31, 2023Omotayo OkusanyaCredit Suisse$13.00$10.6821.72%-28.34%
Dec 27, 2021Michael R LewisTruist Financial$16.00$13.1022.14%-11.80%
Aug 24, 2021Jonathan PetersenJefferies$19.00$15.3523.78%4.74%
May 04, 2021Daniel BernsteinCapital One Financial$20.00$16.4321.73%10.25%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 11, 2024ScotiabankSector PerformSector Performhold
Sep 12, 2024CitigroupNeutralBuyupgrade
Aug 26, 2024ScotiabankSector PerformSector Performhold
Aug 23, 2024Wells FargoEqual-WeightEqual-Weighthold
May 21, 2024CitigroupNeutralNeutralhold
May 15, 2024ScotiabankSector PerformSector Performhold
Oct 10, 2023Bank of America SecuritiesNeutralBuyupgrade
Sep 20, 2023JefferiesBuyupgrade
Aug 11, 2023Bank of America SecuritiesNeutralupgrade
May 31, 2023Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.67$-0.52$-0.34$0.06$0.54----
Avg Forecast$0.67$-0.28$0.14$0.12$0.51$0.70$0.75$0.79-
High Forecast$0.71$-0.26$0.15$0.12$0.51$0.72$0.81$0.84-
Low Forecast$0.62$-0.29$0.13$0.12$0.49$0.68$0.72$0.74-
Surprise %-85.71%-342.86%-50.00%5.88%----

Revenue Forecast

$500M $600M $700M $800M $900M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$598.57M$569.54M$624.81M$647.51M$703.24M----
Avg Forecast$593.73M$581.47M$599.63M$647.02M$686.97M$739.76M$782.38M$866.17M$914.11M
High Forecast$617.35M$604.60M$629.79M$651.41M$688.31M$756.24M$786.45M$898.19M$958.63M
Low Forecast$560.66M$549.08M$555.79M$644.70M$685.03M$722.35M$778.30M$834.15M$870.26M
Surprise %0.82%-2.05%4.20%0.08%2.37%----

Net Income Forecast

$-250M $-160M $-70M $20M $110M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$138.42M$-113.26M$-77.61M$13.76M$126.71M----
Avg Forecast$140.36M$-141.10M$-155.95M$13.76M$117.15M$162.57M$185.05M$189.97M-
High Forecast$168.43M$-94.74M$-105.10M$18.24M$119.22M$166.93M$188.21M$195.55M-
Low Forecast$112.29M$-187.47M$-206.81M$9.27M$115.08M$158.20M$167.30M$172.44M-
Surprise %-1.38%-19.73%-50.24%-8.17%----

SBRA Forecast FAQ

Is Sabra Health Care REIT stock a buy?

Sabra Health Care REIT stock has a consensus rating of Hold, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 12 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Sabra Health Care REIT is a neutral investment for most analysts.

What is Sabra Health Care REIT's price target?

Sabra Health Care REIT's price target, set by 21 Wall Street analysts, averages $17.29 over the next 12 months. The price target range spans from $13 at the low end to $20 at the high end, suggesting a potential -4.69% change from the previous closing price of $18.14.

How does Sabra Health Care REIT stock forecast compare to its benchmarks?

Sabra Health Care REIT's stock forecast shows a -4.69% downside, underperforming the average forecast for the real estate stocks sector (20.09%) and underperforming the healthcare reit stocks industry (17.97%).

What is the breakdown of analyst ratings for Sabra Health Care REIT over the past three months?

  • April 2025: 7.14% Strong Buy, 42.86% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 7.14% Strong Buy, 42.86% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 7.14% Strong Buy, 42.86% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Sabra Health Care REIT’s EPS forecast?

Sabra Health Care REIT's average annual EPS forecast for its fiscal year ending in December 2025 is $0.7, marking a 29.63% increase from the reported $0.54 in 2024. Estimates for the following years are $0.75 in 2026, $0.79 in 2027, and $0 in 2028.

What is Sabra Health Care REIT’s revenue forecast?

Sabra Health Care REIT's average annual revenue forecast for its fiscal year ending in December 2025 is $739.76M, reflecting a 5.19% increase from the reported $703.24M in 2024. The forecast for 2026 is $782.38M, followed by $866.17M for 2027, and $914.11M for 2028.

What is Sabra Health Care REIT’s net income forecast?

Sabra Health Care REIT's net income forecast for the fiscal year ending in December 2025 stands at $162.57M, representing an 28.30% increase from the reported $126.71M in 2024. Projections indicate $185.05M in 2026, $189.97M in 2027, and $0 in 2028.